Renin-angiotensin-aldosterone system inhibition decreased contrast-associated acute kidney injury in chronic kidney disease patients.

CONCLUSION: RASi use in patients with CKD prior to contrast CT has the potential to mitigate the incidence of AKI and hospital mortality. Even a low dose of RASi will noticeably decrease the risk of AKI and will not increase the risk of hyperkalemia.
PMID: 32762878 [PubMed - as supplied by publisher]

Source: J Formos Med Assoc - August 2, 2020 Category: General Medicine Authors: Chen YT, Chan CK, Li WY, Huang TM, Lai TS, Wu VC, Chu TS, National Taiwan University Hospital Study Group on Acute Renal Failure (NSARF) Tags: J Formos Med Assoc Source Type: research